Sagimet Biosciences Inc Q1 2026 Earnings Narrowed Loss Beats Expectations as Clinical Pipeline Advances Woodward WWD Q1 2026 Earnings EPS Surpasses Estimates by 782 Stock Edges Lower CYN Q1 2026 Earnings EPS Surprise of 264 Highlights Cost Discipline Amid Revenue Void MTNB Q4 2024 Earnings Narrowed Loss Surpasses Expectations Pipeline Momentum Continues CLNE Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Management Efforts Rollins Inc ROL Q1 2026 Earnings EPS Edges Past Estimates Shares Dip Slightly